Status:
UNKNOWN
Objective and Perceived Health Status of Elderly People With Moderate or Severe Haemophilia in France: an Ancillary Study of the FranceCoag Registry
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Moderate or Serious Haemophilia
Eligibility:
All Genders
60-100 years
Brief Summary
Background: Elderly people with serious haemophilia (PwSH), i.e., with moderate or severe haemophilia, have major comorbidities due to consequences of haemophilia. Also, the comorbidities related to ...
Eligibility Criteria
Inclusion
- People with serious haemophilia, i.e., with (A or B) moderate or severe haemophilia;
- People aged 60 years or over;
- People included in the FranceCoag registry;
- People followed in one of the Haemophilia Treatment Centre participating in the study;
- People who do not oppose to participate in the study.
Exclusion
- People with comprehension disabilities;
- Participants who a posteriori oppose to participate in the study.
Key Trial Info
Start Date :
April 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
612 Patients enrolled
Trial Details
Trial ID
NCT05218772
Start Date
April 19 2022
End Date
December 31 2023
Last Update
June 8 2023
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Amiens
Amiens, France
2
Ch Annecy - St Julien
Annecy, France
3
Chu de Besancon
Besançon, France
4
Chu de Bordeaux
Bordeaux, France